Results for: Patanjali Ayurved

The Supreme Court has questioned the center and the Indian Medical Association (IMA) over misleading advertisements by Baba Ramdev’s Patanjali Ayurved. The court expressed concern over the omission of Rule 170 from the Drugs and Magical Remedies (Objectionable Advertisements) Act, which prohibits ads claiming “magical” abilities, and asked why the government had backtracked on its implementation. The court also criticized authorities for allegedly prioritizing revenue over consumer protection and referred to instances where Patanjali’s ads appeared on television news channels during reports on the trial. Additionally, the court questioned the IMA’s potential laxity in standards for advertisements for allopathic medical products and asked the association to address concerns about unethical practices within its own ranks.

The Supreme Court intensified its scrutiny of deceptive advertising, emphasizing the need to protect vulnerable groups such as children, babies, and women. The court expressed alarm at the Union government’s lax oversight and urged immediate action to safeguard these populations from misleading marketing practices. The ongoing case against Patanjali Ayurved has been expanded to include key government ministries and state licensing authorities to ensure comprehensive evaluation of advertising regulations.